Dermatomyositis

A type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.

Muscle weakness

Reduced strength of muscles.


Total: 41

                       


(per page)
PMID (PMCID)
31153385
 OTHER
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.
J Med Case Rep. 2019;13(1):168.
However, according to his characteristic skin lesions, the type of muscle weakness, his serum marker profiles, electromyography of his deltoid muscle, and magnetic resonance imaging, he was finally diagnosed as having paraneoplastic dermatomyositis.
29526968
(6120830)
 MALE Adult
Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis.
Kudo F, Watanabe Y, Iwai Y, Miwa C, Nagai Y, Ota H, Yabe H, Demitsu T, Hagiwara K, Koyama N, Koyama S.
Intern Med. 2018;57(15):2217-2221.
It is important to consider drug-associated dermatomyositis in the differential diagnosis of patients presenting with skin lesions and muscle weakness after nivolumab treatment.
29301801
 MALE Middle Aged
Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
Parperis K, Kiyani A.
BMJ Case Rep. 2018;2018:.
Patient had no muscle weakness and his rash was characteristic of classic dermatomyositis.
29301801
 MALE Middle Aged
Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
Parperis K, Kiyani A.
BMJ Case Rep. 2018;2018:.
Clinically amyopathic dermatomyositis (CADM) is a rare entity that presents with cutaneous manifestations of classic dermatomyositis but without muscle weakness or abnormal muscle enzymes.
30567206
 MALE
Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer.
Laidler NK.
BMJ Case Rep. 2018;11(1):.
Patients with dermatomyositis display characteristic skin changes in addition to muscle weakness.
30039536
 FEMALE Young Adult
Seronegative dermatomyositis presenting with features of anti-MDA5 subtype.
Ahmed A, Scarborough R, Gabriela R, Fernandez AP, Bergfeld W.
J Cutan Pathol. 2018;45(11):851-854.
Dermatomyositis is a chronic inflammatory disorder of muscles and skin, presenting with muscle weakness, characteristic rash, and classic serology findings.
30357036
(6197508)
 OTHER
Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis.
Malik ZR, Shahbaz A, Aziz K, Razaq Z, Umair M, Sachmechi I.
Cureus. 2018;10(8):e3161.
Dermatomyositis is an inflammatory myopathy which causes a distinctive skin rash and muscle weakness.
31037177
 FEMALE Infant, Newborn
[Neonatal lupus in an infant of a mother followed up for dermatomyositis: medical images].
Cisse L, Karabinta Y.
Pan Afr Med J. 2018;31:117.
Her mother was followed up for dermatomyositis diagnosed on the basis of clinical lesions, muscle weakness and elevation in muscle enzyme levels.
28824190
 FEMALE
A Case of Dermatomyositis with Severe Myalgia and Muscle Weakness Testing Positive for Anti-melanoma Differentiation-associated Gene 5 Antibody.
Yamazaki K, Wakabayashi H, Suganami Y, Sano S, Wakunami Y, Katayama T, Deguchi K, Nagotani S, Kishida M.
Acta Med Okayama. 2017;71(4):341-344.
We report a case of a woman with typical dermatomyositis (DM) with skin manifestations, severe myalgia and muscle weakness complicated by interstitial lung disease (ILD) and pneumomediastinum.
28768982
(5577088)
 MALE
Multicentric Reticulohistiocytosis with Dermatomyositis-like Eruptions.
Shima N, Murosaki T, Nagashima T, Iwamoto M, Amano Y, Nakano N, Ohtsuki M, Minota S.
Intern Med. 2017;56(15):2063-2066.
Initially, dermatomyositis (DM) was considered because of the erythema, polyarthritis, and muscle weakness.
28695037
(5485271)
 OTHER
NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation.
Butt Z, Patel L, Das MK, Mecoli CA, Ramji A.
Case Rep Rheumatol. 2017;2017:4817275.
Dermatomyositis (DM), a myopathy associated with inflammation and muscle weakness, has historically been difficult to diagnose.
26851947
(4744381)
 FEMALE Adult
A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report.
Papakonstantinou E, Kapp A, Raap U.
J Med Case Rep. 2016;10:34.
Here we report a case of a woman with dermatomyositis who was diagnosed with lung adenocarcinoma in the setting of weight loss, progressive fatigue and muscle weakness.
26759443
 FEMALE Middle Aged
Colonic vasculopathy and perforation in the initial presentation of adult dermatomyositis in a patient with improving muscle weakness.
Kibbi N, Bekui A, Buckley LM.
BMJ Case Rep. 2016;2016:.
Colonic vasculopathy and perforation in the initial presentation of adult dermatomyositis in a patient with improving muscle weakness.
24609759
 MIXED_SAMPLE Adult
Tuberculous pyomyositis: a re-emerging entity of many faces.
Simopoulou T, Varna A, Dailiana Z, Katsiari C, Alexiou I, Basdekis G, Malizos KN, Sakkas LI.
Clin Rheumatol. 2016;35(4):1105-10.
We present three patients diagnosed with TB pyomyositis: a 46-year-old man with dermatomyositis (DM) and hepatitis B who presented with fever, muscle weakness, and an abscess at the right proximal arm; a 71-year-old immunocompetent male, with a past medical history of tuberculous lymphadenopathy in childhood, who presented with a 2-month history of fever and pain at the right thigh, and a 44-year-old woman with systemic lupus erythematosus (SLE) on prednisone and methotrexate who presented with skin eruption at her thighs mimicking lupus panniculitis.
27274638
(4884716)
 OTHER
Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis.
Doh EJ, Moon J, Shin S, Seo SH, Park HS, Yoon HS, Cho S.
Ann Dermatol. 2016;28(3):375-80.
Both patients were diagnosed with juvenile-onset amyopathic dermatomyositis based on histopathology and cutaneous manifestations with no evidence of muscle weakness and no serum muscle enzyme abnormalities.
25321335
 FEMALE Middle Aged
Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
Sheik Ali S, Goddard AL, Luke JJ, Donahue H, Todd DJ, Werchniak A, Vleugels RA.
JAMA Dermatol. 2015;151(2):195-9.
Physicians should be aware of these potential immune-related adverse events and consider drug-associated dermatomyositis in the differential diagnosis in patients receiving ipilimumab who present with a cutaneous eruption or muscle weakness.
25030569
 FEMALE
Amyopathic dermatomyositis complicated with eosinophilic pneumonia.
Iijima Y, Furusawa H, Tateishi T, Tsuchiya K, Fujie T, Tamaoka M, Sakashita H, Miyazaki Y, Sumi Y, Hosono Y, Nakashima R, Mimori T, Inase N.
Intern Med. 2014;53(14):1539-44.
The patient also exhibited heliotrope eyelids without muscle weakness, which led to a diagnosis of amyopathic dermatomyositis (ADM).
22466843
 MALE Middle Aged
Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies.
Sugie K, Tonomura Y, Ueno S.
Intern Med. 2012;51(7):799-802.
We describe a patient with dermatomyositis who presented with rapidly developing severe muscle weakness complicated by massive pleural effusion with interstitial lung disease.
21224460
(4047218)
 FEMALE Child
Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.
Rider LG, Miller FW.
JAMA. 2011;305(2):183-90.
The idiopathic inflammatory myopathies or myositis syndromes (the most common forms are polymyositis, dermatomyositis, and inclusion body myositis) are systemic autoimmune diseases defined by chronic muscle weakness and inflammation of unknown etiology and result in significant morbidity and mortality.
22674111
 FEMALE
Simultaneously developed polymyositis and autoimmune hepatitis.
Hounoki H, Shinoda K, Ogawa R, Taki H, Tsuneyama K, Tobe K.
BMJ Case Rep. 2011;2011:.
The inflammatory myopaties such as polymyositis (PM) and dermatomyositis (DM) are autoimmune inflammatory muscle disorders characterised by the development of proximal and often symmetrical muscle weakness.